Blue Water Acquisition Corp. (BLUW) Shareholders Approve Clarus Therapeutics Deal
Blue Water Acquisition Corp. (NASDAQ:BLUW) announced in a press release today that its shareholders approved its combination with pharmaceutical firm Clarus Therapeutics earlier this morning. A total of 3,270,531 shares were redeemed in connection with the meeting, leaving approximately $25 million remaining in the trust, which was estimated to hold $58.7 million going into theRead More